Langar Global HealthTech ETF
LGHT
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- 13346 Marigold Way San Diego CA United States of America 92130
- IPO Date
- Jan 10, 2024
- Website
- digital.fidelity.com
- Similar Companies
- Business
- Langar Global HealthTech ETF (LGHT) is an actively managed exchange-traded fund that seeks long-term capital growth by investing primarily in U.S. and foreign exchange-listed equity securities of healthcare technology companies, including American Depository Receipts (ADRs), across all market capitalizations; the fund normally allocates at least 80% of its net assets (plus borrowings for investment purposes) to such securities, focusing on firms that develop technologies to enhance healthcare efficiency for patients, providers, payors, and hospitals. Top holdings include Intuitive Surgical Inc. (ISRG), Siemens Healthineers AG (SMMNY), ResMed Inc. (RMD), Veeva Systems Inc. (VEEV), IQVIA Holdings Inc. (IQV), Insulet Corp. (PODD), Dexcom Inc. (DXCM), GE HealthCare Technologies Inc. (GEHC), Koninklijke Philips NV (PHG), and Zimmer Biomet Holdings Inc. (ZBH), representing approximately 73.7% of the portfolio as of recent data, with a total of around 31-32 holdings diversified across healthcare equipment, biotechnology, health care technology, and related subsectors. The ETF operates globally with primary exposure to developed markets in the United States (about 72%), Eurozone (18%), and other regions including Europe ex-Euro and Australasia; it is part of the Spinnaker ETF Series, advised by Langar Investment Management, LLC, with Dhruv Vig as portfolio manager, a net expense ratio of 0.85%, and distributed by Capital Investment Group, Inc.. Launched on January 10, 2024, and headquartered in the United States through its advisor, LGHT represents the first pure-play health tech ETF, addressing gaps in traditional healthcare ETF models via active management amid projected U.S. AI healthcare market growth from $8.45 billion in 2024 to $194.88 billion by 2034. Recent developments include portfolio evolution with updated top holdings reflecting market performance, share repurchases of 50,000 shares in its first annual period ending post-inception, and ongoing emphasis by CEO Dhruv Vig on innovative active strategies, with total net assets fluctuating around $2.5-4.1 million and shares outstanding near 410,000 as of late 2025.